Literature DB >> 31892558

Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.

Toshiaki Tanaka1, Takashi Kobunai2, Yoko Yamamoto3, Koji Murono3, Shigenbu Emoto3, Masaya Hiyoshi3, Manabu Kaneko3, Kazuhito Sasaki3, Yasutaka Shuno3, Takeshi Nishikawa3, Keisuke Hata3, Kazushige Kawai3, Hiroaki Nozawa3, Soichiro Ishihara3.   

Abstract

BACKGROUND: Mitochondria are energy-producing organelles, and dysfunction in these organelles causes various types of disease. Although several studies have identified mutations in nuclear DNA that are associated with the etiology of ulcerative colitis (UC), information regarding mitochondrial DNA (mtDNA) in UC is limited. This study aimed to investigate the mitochondrial DNA polymorphism underlying the etiology of UC and UC-associated colorectal cancer.
MATERIALS AND METHODS: Next-generation sequencing was performed to assess mitochondrial DNA mutations in 12 patients with UC-associated cancer. The mtDNA mutations in the non-neoplastic mucosa, tumor tissues, and healthy controls were compared.
RESULTS: The incidence of mutations of nicotinamide adenine dinucleotide phosphate ubiquinone oxidase subunit, ATP synthetase, and tRNA was higher in non-neoplastic mucosa in those with UC compared with the healthy controls. However, no statistically significant differences were observed in mutations between the tumor tissues and non-neoplastic mucosa in UC.
CONCLUSION: Significant mutations in mtDNA were observed in the non-neoplastic mucosa of patients with UC-associated cancer. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ulcerative colitis; carcinogenesis; mtDNA

Mesh:

Year:  2020        PMID: 31892558     DOI: 10.21873/anticanres.13931

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Analysis of the Efficacy and Pharmacological Mechanisms of Action of Zhenren Yangzang Decoction on Ulcerative Colitis Using Meta-Analysis and Network Pharmacology.

Authors:  Guosheng Xing; Yufeng Zhang; Xinlin Wu; Hua Wang; Yan Liu; Zhen Zhang; Mingxing Hou; Haibing Hua
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.